Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Malancha Ta"'
Autor:
Srishti Dutta Gupta, Malancha Ta
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-22 (2024)
Abstract Mesenchymal stem cells (MSCs) are known to facilitate angiogenesis and promote neo-vascularization via secretion of trophic factors. Here, we explored the molecular mechanism adopted by ADAMTS13 in modulating the expression of some key angio
Externí odkaz:
https://doaj.org/article/0334b8c64e56478497a8d6f79372f7ef
Publikováno v:
STAR Protocols, Vol 4, Iss 3, Pp 102498- (2023)
Summary: Mesenchymal stem cells (MSCs), also referred to as “medicinal signaling cells,” have gained prominence as candidates for cell-based therapy and in clinical trials owing to their regenerative and therapeutic properties. Here, we present a
Externí odkaz:
https://doaj.org/article/a180c15211da446cb7e810defcb31090
Autor:
Umesh Goyal, Malancha Ta
Publikováno v:
Stem Cell Research & Therapy, Vol 11, Iss 1, Pp 1-14 (2020)
Abstract Background Due to their immunomodulatory and trophic support functions, mesenchymal stem cells (MSCs) are promising in the field of cell-based regenerative medicine. However, MSC survival post-transplantation is challenged by various microen
Externí odkaz:
https://doaj.org/article/065eef87f9a043ca9603157e8066bb31
Publikováno v:
StemJournal. 5:1-17
BACKGROUND: Due to their anti-inflammatory and immunomodulatory capabilities, mesenchymal stem cells (MSCs) are being widely used in cell-based therapies for the treatment of a wide spectrum of inflammatory disorders. Despite their promises, substant
Publikováno v:
Bio-Protocol, Vol 8, Iss 4 (2018)
Mesenchymal stem cells (MSCs) are currently considered as ‘medicinal signaling cells’ and a promising resource in regard to cell-based regenerative therapy. Umbilical cord is a human term perinatal tissue which is easily attainable, and a promisi
Externí odkaz:
https://doaj.org/article/83c86e15741d4a60bdd3d8b94582818c
Publikováno v:
Stem Cells International, Vol 2017 (2017)
The efficacy of mesenchymal stem cell (MSC) therapy is currently limited by low retention and poor survival of transplanted cells as demonstrated by clinical studies. This is mainly due to the harsh microenvironment created by oxygen and nutrient dep
Externí odkaz:
https://doaj.org/article/08b233f30ee7416798e540a92c310104
Autor:
S. Ghosh, Ananya Das, Ankita Sen, Malancha Ta, Mrinal Kanti Mandal, Tanmay Chatterjee, Saptarshi Mandal, Prasun K. Mandal, Chayan K. De, Debjit Roy
Publikováno v:
The Journal of Physical Chemistry C. 124:27049-27054
Contrary to the belief of the chemistry community, intense charge transfer is observed between meta-oriented donor–acceptor moieties in ultrasmall single-benzenic fluorophores. Red emission in any ...
Due to their anti-inflammatory and immunomodulatory capabilities, mesenchymal stem cells (MSCs) are being widely used in cell-based therapies for the treatment of a wide spectrum of inflammatory disorders. Despite their promises, substantial cell los
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::aafa824164d2e4c45984bc16cfd0f8a3
https://doi.org/10.1101/2022.02.23.481475
https://doi.org/10.1101/2022.02.23.481475
Autor:
Ankita Sen, Malancha Ta
Publikováno v:
Experimental Cell Research. 423:113467
Mesenchymal stem cell (MSC)-based therapy gets compromised as adverse microenvironmental conditions like nutrient deprivation, ischemia, hypoxia at the target site affect migration, engraftment and viability, of MSCs post transplantation. To improve
Publikováno v:
International Journal of Biological Sciences, Vol 6, Iss 5, Pp 499-512 (2010)
Multipotent mesenchymal stromal cells (MSCs) from Wharton's jelly (WJ) of umbilical cord bear higher proliferation rate and self-renewal capacity than adult tissue-derived MSCs and are a primitive stromal cell population. Stem cell niche or physiolog
Externí odkaz:
https://doaj.org/article/7fef4d7b27714beaab1c0603da47d852